Development of Small Molecule Probes for the Selective Modification and Labeling of the Mycobacterial Cell Wall

NIH RePORTER · NIH · F32 · $19,251 · view on reporter.nih.gov ↗

Abstract

PROJECT SUMMARY/ABSTRACT All cells throughout the three domains of life are coated in an array of structurally and compositionally diverse glycans which play a key role in cell signaling and recognition. In eukaryotic systems, a number of strategies for the perturbation of these structures with unnatural sugar probes have been disclosed. These probes have proven to be a powerful tool for interrogating glycan structure, function and dynamics in living systems. However, because these techniques all rely on extensive metabolic processing of the probe prior to incorporation, they have been largely ineffective in bacteria, which utilize a multitude of catabolic pathways that can degrade and reconstitute parts of the probe on the way to the final destination. This proposal aims to circumvent this problem by designing small molecule probes that engage directly with the extracellular enzymes that construct important cell wall motifs. This strategy, termed ‘biosynthetic incorporation’ will be applied to the selective modification of two important glycolipid virulence factors within the cell wall of Mycobacterium tuberculosis (Mtb), the lipoarabinomannan (LAM) and trehalose dimycolate (TDM), which help the pathogen infect host cells and evade the body’s immune defense system. This proposal focuses primarily on the design and synthesis of azide-modified arabinofuranose, mannose and mycolic acid probes and studies intended to quantify the degree of incorporation and distribution of the probes. The tools developed in the course of this work will be used to visualize the localization and dynamics of the LAM and TDM during host cell infection using live cell imaging. Insights gleaned from these studies could elucidate new strategies for the treatment of mycobacterial diseases like Mtb. The Kiessling research group at the Massachusetts Institute of Technology (MIT) is an ideal environment to pursue the research outlined in this proposal and to achieve the training goals that will prepare me for a career in academia. In the Kiessling group, I will be able to continue to hone and utilize my skills in synthetic organic chemistry while also gaining expertise in a diverse array of new techniques including microscopy, microbiology, flow cytometry and cell culture. I will have the opportunity to mentor undergraduates and graduate students within the group. In addition to this, the MIT Teaching and Learning Lab provides programming and a number of resources that I will utilize in order to continue to build my teaching skills. I am confident that the exceptional laboratory and institutional environment at MIT will provide me with the tools necessary for a successful independant career.

Key facts

NIH application ID
10394129
Project number
5F32GM142288-02
Recipient
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Principal Investigator
Daria Eldarovna Kim
Activity code
F32
Funding institute
NIH
Fiscal year
2022
Award amount
$19,251
Award type
5
Project period
2021-04-06 → 2022-06-30